You have access
Angiotensinogen Polymorphism is Associated with Risk for Malignancy but not for Oral Cancer
ELEFTHERIOS VAIRAKTARIS, CHRISTOS YAPIJAKIS, ANTONIS VYLLIOTIS, SPYRIDOULA DERKA, STAVROS VASSILIOU, EMEKA NKENKE, ZOE SEREFOGLOU, VASILEIOS RAGOS, ELENA CRITSELIS, DIMITRIOS AVGOUSTIDIS, FRIEDRICH NEUKAM and EFSTRATIOS PATSOURIS
Anticancer Research May 2008, 28 (3A) 1675-1679;